Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Clinical Study to Evaluate the Efficacy and Safety of AK111 in the Treatment of Subjects With Active Ankylosing Spondylitis

NCT06378697 is registered in ClinicalTrials.gov with Akeso as lead sponsor.

NCT NCT06378697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06378697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Clinical Study to Evaluate the Efficacy and Safety of AK111 in the Treatment of Subjects With Active Ankylosing Spondylitis
Lead sponsor
Akeso
Phase
Phase 3
Overall status
Completed
Start date
November 22, 2023
Completion date
November 7, 2025
Enrollment
510 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis